海角破解版

EasySep? Human Na?ve CD8+ T Cell Isolation Kit II

Immunomagnetic negative isolation of untouched human na?ve CD8+ T cells

EasySep? Human Na?ve CD8+ T Cell Isolation Kit II

Immunomagnetic negative isolation of untouched human na?ve CD8+ T cells

Catalog #
(Select a product)
Immunomagnetic negative isolation of untouched human na?ve CD8+ T cells
Request Pricing Request Pricing

Product Advantages


  • Fast, easy-to-use and column-free

  • Up to 97% purity

  • Untouched, viable cells

What's Included

  • EasySep? Human Na?ve CD8+ T Cell Isolation Kit II (Catalog #17968)
    • EasySep? Human Na?ve CD8+ T Cell Isolation Cocktail, 1 mL
    • EasySep? Dextran RapidSpheres?, 1 x 1 mL
  • RoboSep? Human Naive CD8+ T Cell Isolation Kit (Catalog #17968RF)
    • EasySep? Human Na?ve CD8+ T Cell Isolation Cocktail, 1 mL
    • EasySep? Dextran RapidSpheres?, 1 x 1 mL
    • RoboSep? Buffer (Catalog #20104)
    • RoboSep? Filter Tips (Catalog #20125)
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Easily and efficiently isolate highly purified human na?ve CD8+ T cells (CD8+CD45RA+CCR7+ and CD45RO-CD57-CD56-) from fresh human peripheral blood mononuclear cell (PBMC) samples by immunomagnetic negative selection, with the EasySep? Human Na?ve CD8+ T Cell Isolation Kit II. Widely used in published research for more than 20 years, EasySep? combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.

In this EasySep? negative selection procedure, unwanted cells are labeled with antibody complexes and magnetic particles. Unwanted cells expressing the following markers are targeted for removal: CD4, CD14, CD16, CD19, CD20, CD36, CD56, CD94, CD123, CD244, IgM, GlyA, TCRgd, CD45RO, and CD57. The magnetically labeled cells are then separated from the untouched desired na?ve CD8+ T cells by using an EasySep? magnet and simply pouring or pipetting the desired cells into a new tube. Following magnetic cell isolation in as little as 11 minutes, the desired na?ve CD8+ T cells are ready for downstream applications such as flow cytometry, culture, or DNA/RNA extraction.

This product replaces the EasySep? Human Na?ve CD8+ T Cell Enrichment Kit (Catalog #19258) for even faster cell isolations.

Learn more about how immunomagnetic EasySep? technology works or how to fully automate immunomagnetic cell isolation with RoboSep?. Alternatively, choose ready-to-use, ethically sourced, primary Human Peripheral Blood CD8+CD45RA+ T Cells, Frozen isolated with EasySep? Human Na?ve CD8+ T Cell Isolation Kit II. Explore additional products optimized for your workflow, including culture media, supplements, antibodies, and more.
Magnet Compatibility
? EasySep? Magnet (Catalog #18000)
? “The Big Easy” EasySep? Magnet (Catalog #18001)
? EasyEights? EasySep? Magnet (Catalog #18103)
? RoboSep?-S (Catalog #21000)
Subtype
Cell Isolation Kits
Cell Type
T Cells, T Cells, CD8+
Species
Human
Sample Source
PBMC
Selection Method
Negative
Application
Cell Isolation
Brand
EasySep, RoboSep
Area of Interest
Immunology

Data Figures

Figure 1. Typical EasySep? Human Naive CD8 T Cell Isolation Profile

Starting with fresh PBMCs, the na?ve CD8+ T cell content (CD8+CD45RA+CCR7+ and CD45RO-CD57-CD56-) of the isolated fraction is typically 93.7 ± 2.4% (mean ± SD), using the purple EasySep? Magnet. In the above example, the purities of the start and final isolated fractions are 6.8% and 94.2%, respectively.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
17968RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17968
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (5)

LINC01871 is exclusively expressed in T and NK cells and is highly induced upon CD4+ T cell activation U. Kalim et al. iScience 2025 Oct

Abstract

SummaryLong intergenic noncoding RNAs (lincRNAs) regulate biological processes in health and disease. Recent findings highlight the importance of lincRNAs in regulating T cell development and function. Here, we identified a lincRNA, LINC01871, which is highly induced upon CD4+ T cell activation and is predominantly located in the cytoplasm. The anti-inflammatory cytokine TGF-β was found to suppress its expression. Silencing LINC01871 led to a modest decrease in IL-2 secretion. Notably, LINC01871 expression was highly specific to NK cells and T cells in several cross-tissue single cell RNA-seq atlases. These data suggest that LINC01871 is specifically expressed in T and NK cells and may contribute to T cell-mediated immunity in humans. Graphical abstract Highlights?LINC01871 is a cytoplasmic lincRNA induced upon CD4+ T cell activation?TGF-β negatively regulates LINC01871 expression?Expression of LINC01871 is restricted to effector and memory T and NK cells Immunology; Molecular biology; Cell biology
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis I. Nikolic et al. EMBO Reports 2024 May

Abstract

Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8+ T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function. Synopsis The p38 pathway regulates T cell-mediated adipose tissue inflammation and browning via IL-35. Lack of p38 activation in T cells increases IL-35, thereby inducing thermogenesis and reducing inflammation. T cell-specific deletion of p38 activators protects against diet-induced obesity, improves metabolic profiles, and enhances browning and thermogenesis.The p38 pathway plays a pivotal role in regulating T cell-mediated adipose tissue inflammation and browning.IL-35 is a significant driver of adipocyte thermogenesis and suppression of adipose tissue inflammation.The p38 pathway controls IL-35 expression in human and mouse regulatory T cells through mTOR pathway activation. The p38 pathway regulates T cell-mediated adipose tissue inflammation and browning via IL-35. Lack of p38 activation in T cells increases IL-35, thereby inducing thermogenesis and reducing inflammation.
Induction of memory-like CD8+ T cells and CD4+ T cells from human naive T cells in culture. Y. Tokumoto et al. Clinical and experimental immunology 2022 jan

Abstract

Memory T cells are crucial players in vertebrate adaptive immunity but their development is incompletely understood. Here, we describe a method to produce human memory-like T cells from naive human T cells in culture. Using commercially available human T-cell differentiation kits, both purified naive CD8+ T cells and purified naive CD4+ T cells were activated via T-cell receptor signaling and appropriate cytokines for several days in culture. All the T-cell activators were then removed from the medium and the cultures were continued in hypoxic condition (1% O2 atmosphere) for several more days; during this period, most of the cells died, but some survived in a quiescent state for a month. The survivors had small round cell bodies, expressed differentiation markers characteristic of memory T cells and restarted proliferation when the T-cell activators were added back. We could also induce memory-like T cells from naive human T cells without hypoxia, if we froze the activated T cells or prepared the naive T cells from chilled filter buffy coats.